{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:08:45Z","timestamp":1793916525980,"version":"4.8.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772530"],"award-info":[{"award-number":["81772530"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Hyocholic acid (HCA) is a major bile acid (BA) species in the BA pool of pigs, a species known for its exceptional resistance to spontaneous development of diabetic phenotypes. HCA and its derivatives are also present in human blood and urine. We investigate whether human HCA profiles can predict the development of metabolic disorders. We find in the first cohort (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20091107) that both obesity and diabetes are associated with lower serum concentrations of HCA species. A separate cohort study (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200991) validates this finding and further reveals that individuals with pre-diabetes are associated with lower levels of HCA species in feces. Serum HCA levels increase in the patients after gastric bypass surgery (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200938) and can predict the remission of diabetes two years after surgery. The results are replicated in two independent, prospective cohorts (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009132 and\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009207), where serum HCA species are found to be strong predictors for metabolic disorders in 5 and 10 years, respectively. These findings underscore the association of HCA species with diabetes, and demonstrate the feasibility of using HCA profiles to assess the future risk of developing metabolic abnormalities.\n                  <\/jats:p>","DOI":"10.1038\/s41467-021-21744-w","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T06:03:22Z","timestamp":1614924202000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":140,"title":["Hyocholic acid species as novel biomarkers for metabolic disorders"],"prefix":"10.1038","volume":"12","author":[{"given":"Xiaojiao","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianlu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangchi","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junliang","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqian","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengci","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuiping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Rajani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxiang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3075-2161","authenticated-orcid":false,"given":"Yike","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6244-2168","authenticated-orcid":false,"given":"Weiping","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3739-8994","authenticated-orcid":false,"given":"Wei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,5]]},"reference":[{"key":"21744_CR1","doi-asserted-by":"crossref","unstructured":"Neeland IJ, Poirier P, Despres JP. Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management. Circulation 137, 1391\u20131406 (2018).","DOI":"10.1161\/CIRCULATIONAHA.117.029617"},{"key":"21744_CR2","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1056\/NEJMra0906948","volume":"363","author":"MI McCarthy","year":"2010","unstructured":"McCarthy, M. I. GENOMIC MEDICINE Genomics, Type 2 diabetes, and obesity. New Engl. J. Med. 363, 2339\u20132350 (2010).","journal-title":"New Engl. J. Med."},{"key":"21744_CR3","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1172\/JCI57132","volume":"121","author":"CN Lumeng","year":"2011","unstructured":"Lumeng, C. N. & Saltiel, A. R. Inflammatory links between obesity and metabolic disease. J. Clin. Investig. 121, 2111\u20132117 (2011).","journal-title":"J. Clin. Investig."},{"key":"21744_CR4","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S2213-8587(13)70062-7","volume":"1","author":"N Stefan","year":"2013","unstructured":"Stefan, N., Haring, H. U., Hu, F. B. & Schulze, M. B. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol. 1, 152\u2013162 (2013).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"21744_CR5","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1210\/jc.2011-3475","volume":"97","author":"M Hamer","year":"2012","unstructured":"Hamer, M. & Stamatakis, E. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J. Clin. Endocr. Metab. 97, 2482\u20132488 (2012).","journal-title":"J. Clin. Endocr. Metab."},{"key":"21744_CR6","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.2337\/diacare.27.9.2222","volume":"27","author":"MP St-Onge","year":"2004","unstructured":"St-Onge, M. P., Janssen, I. & Heymsfield, S. B. Metabolic syndrome in normal-weight Americans\u2014new definition of the metabolically obese, normal-weight individual. Diabetes Care 27, 2222\u20132228 (2004).","journal-title":"Diabetes Care"},{"key":"21744_CR7","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.ebiom.2015.09.004","volume":"2","author":"Y Ni","year":"2015","unstructured":"Ni, Y. et al. Circulating unsaturated fatty acids delineate the metabolic status of obese individuals. Ebiomedicine 2, 1513\u20131522 (2015).","journal-title":"Ebiomedicine"},{"key":"21744_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","volume":"24","author":"A Wahlstrom","year":"2016","unstructured":"Wahlstrom, A., Sayin, S. I., Marschall, H. U. & Backhed, F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 24, 41\u201350 (2016).","journal-title":"Cell Metab."},{"key":"21744_CR9","doi-asserted-by":"publisher","first-page":"R85","DOI":"10.1530\/JOE-15-0469","volume":"228","author":"L Vitek","year":"2016","unstructured":"Vitek, L. & Haluzik, M. The role of bile acids in metabolic regulation. J. Endocrinol. 228, R85\u2013R96 (2016).","journal-title":"J. Endocrinol."},{"key":"21744_CR10","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1084\/jem.20171965","volume":"215","author":"H Shapiro","year":"2018","unstructured":"Shapiro, H., Kolodziejczyk, A. A., Halstuch, D. & Elinav, E. Bile acids in glucose metabolism in health and disease. J. Exp. Med. 215, 383\u2013396 (2018).","journal-title":"J. Exp. Med."},{"key":"21744_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-017-0462-7","volume":"15","author":"X Zheng","year":"2017","unstructured":"Zheng, X. et al. Bile acid is a significant host factor shaping the gut microbiome of diet-induced obese mice. BMC Biol. 15, 120 (2017).","journal-title":"BMC Biol."},{"key":"21744_CR12","doi-asserted-by":"publisher","first-page":"4878","DOI":"10.1096\/fj.201700614R","volume":"32","author":"X Zheng","year":"2018","unstructured":"Zheng, X. et al. Food withdrawal alters the gut microbiota and metabolome in mice. FASEB J. 32, 4878\u20134888 (2018).","journal-title":"FASEB J."},{"key":"21744_CR13","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nature04330","volume":"439","author":"M Watanabe","year":"2006","unstructured":"Watanabe, M. et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439 484\u2013489 (2006).","journal-title":"Nature"},{"key":"21744_CR14","doi-asserted-by":"publisher","first-page":"842","DOI":"10.3389\/fphar.2019.00842","volume":"10","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y. et al. Ursodeoxycholic acid alters bile acid and fatty acid profiles in a mouse model of diet-induced obesity. Front. Pharm. 10, 842 (2019).","journal-title":"Front. Pharm."},{"key":"21744_CR15","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1111\/bph.14705","volume":"176","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y. et al. Ursodeoxycholic acid accelerates bile acid enterohepatic circulation. Br. J. Pharm. 176, 2848\u20132863 (2019).","journal-title":"Br. J. Pharm."},{"key":"21744_CR16","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","volume":"152","author":"O Chavez-Talavera","year":"2017","unstructured":"Chavez-Talavera, O., Tailleux, A., Lefebvre, P. & Staels, B. Bile acid control of metabolism and inflammation in obesity, Type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease. Gastroenterology 152, 1679\u2013167 (2017).","journal-title":"Gastroenterology"},{"key":"21744_CR17","doi-asserted-by":"publisher","first-page":"4222","DOI":"10.1210\/jc.2015-2884","volume":"100","author":"HY Yu","year":"2015","unstructured":"Yu, H. Y. et al. Chenodeoxycholic acid as a potential prognostic marker for roux-en-Y gastric bypass in Chinese obese patients. J. Clin. Endocr. Metab. 100, 4222\u20134230 (2015).","journal-title":"J. Clin. Endocr. Metab."},{"key":"21744_CR18","doi-asserted-by":"publisher","unstructured":"Zheng, X. et al. Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism. Cell Metab. https:\/\/doi.org\/10.1016\/j.cmet.2020.11.017 (2020).","DOI":"10.1016\/j.cmet.2020.11.017"},{"key":"21744_CR19","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/ijo.2016.46","volume":"40","author":"V Spinelli","year":"2016","unstructured":"Spinelli, V. et al. Influence of Roux-en-Y gastric bypass on plasma bile acid profiles: a comparative study between rats, pigs and humans. Int J. Obes. 40, 1260\u20131267 (2016).","journal-title":"Int J. Obes."},{"key":"21744_CR20","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1210\/jc.2012-2906","volume":"98","author":"Y Bao","year":"2013","unstructured":"Bao, Y. et al. Inverse relationship between serum osteocalcin levels and visceral fat area in Chinese men. J. Clin. Endocrinol. Metab. 98, 345\u2013351 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"21744_CR21","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s00125-006-0503-1","volume":"50","author":"WP Jia","year":"2007","unstructured":"Jia, W. P. et al. Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communities. Diabetologia 50, 286\u2013292 (2007).","journal-title":"Diabetologia"},{"key":"21744_CR22","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1124\/pr.113.008201","volume":"66","author":"T Li","year":"2014","unstructured":"Li, T. & Chiang, J. Y. Bile acid signaling in metabolic disease and drug therapy. Pharm. Rev. 66, 948\u2013983 (2014).","journal-title":"Pharm. Rev."},{"key":"21744_CR23","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1007\/s11684-018-0644-x","volume":"12","author":"C Rajani","year":"2018","unstructured":"Rajani, C. & Jia, W. Bile acids and their effects on diabetes. Front. Med. 12, 608\u2013623 (2018).","journal-title":"Front. Med."},{"key":"21744_CR24","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1021\/pr500920q","volume":"14","author":"G Xie","year":"2015","unstructured":"Xie, G. et al. Profiling of serum bile acids in a healthy Chinese population using UPLC\u2013MS\/MS. J. Proteome Res. 14, 850\u2013859 (2015).","journal-title":"J. Proteome Res."},{"key":"21744_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8231","volume":"6","author":"S Han","year":"2015","unstructured":"Han, S. et al. Circadian control of bile acid synthesis by a KLF15-Fgf15 axis. Nat. Commun. 6, 7231 (2015).","journal-title":"Nat. Commun."},{"key":"21744_CR26","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/S0022-2275(20)33481-7","volume":"40","author":"WC Duane","year":"1999","unstructured":"Duane, W. C. & Javitt, N. B. 27-hydroxycholesterol: production rates in normal human subjects. J. Lipid Res. 40, 1194\u20131199 (1999).","journal-title":"J. Lipid Res."},{"key":"21744_CR27","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.2337\/db15-0214","volume":"64","author":"E Ferrannini","year":"2015","unstructured":"Ferrannini, E. et al. Increased bile acid synthesis and deconjugation after biliopancreatic diversion. Diabetes 64, 3377\u20133385 (2015).","journal-title":"Diabetes"},{"key":"21744_CR28","doi-asserted-by":"publisher","unstructured":"Jia, W., Wei, M., Rajani, C. & Zheng, X. Targeting the alternative bile acid synthetic pathway for metabolic diseases. Protein Cell https:\/\/doi.org\/10.1007\/s13238-020-00804-9 (2020).","DOI":"10.1007\/s13238-020-00804-9"},{"key":"21744_CR29","doi-asserted-by":"publisher","first-page":"102766","DOI":"10.1016\/j.ebiom.2020.102766","volume":"55","author":"M Wei","year":"2020","unstructured":"Wei, M. et al. A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility. Ebiomedicine 55, 102766 (2020).","journal-title":"Ebiomedicine"},{"key":"21744_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12896-x","volume":"10","author":"F Huang","year":"2019","unstructured":"Huang, F. et al. Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism. Nat. Commun. 10, 4971 (2019).","journal-title":"Nat. Commun."},{"key":"21744_CR31","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3390\/metabo10110475","volume":"10","author":"J Kuang","year":"2020","unstructured":"Kuang, J. et al. Anti-adipogenic effect of theabrownin is mediated by bile acid alternative synthesis via gut microbiota remodeling. Metabolites 10, 475 (2020).","journal-title":"Metabolites"},{"key":"21744_CR32","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fphar.2019.00063","volume":"10","author":"F Huang","year":"2019","unstructured":"Huang, F. et al. Pu-erh tea regulates fatty acid metabolism in mice under high-fat diet. Front. Pharm. 10, 63 (2019).","journal-title":"Front. Pharm."},{"key":"21744_CR33","doi-asserted-by":"publisher","first-page":"154042","DOI":"10.1016\/j.metabol.2019.154042","volume":"103","author":"O Ch\u00e1vez-Talavera","year":"2020","unstructured":"Ch\u00e1vez-Talavera, O. et al. Bile acids associate with glucose metabolism, but do not predict conversion from impaired fasting glucose to diabetes. Metab.-Clin. Exp. 103, 154042 (2020).","journal-title":"Metab.-Clin. Exp."},{"key":"21744_CR34","doi-asserted-by":"publisher","first-page":"1241214","DOI":"10.1126\/science.1241214","volume":"341","author":"VK Ridaura","year":"2013","unstructured":"Ridaura, V. K. et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341, 1241214 (2013).","journal-title":"Science"},{"key":"21744_CR35","doi-asserted-by":"publisher","first-page":"5801","DOI":"10.1021\/pr4008199","volume":"12","author":"Y Gu","year":"2013","unstructured":"Gu, Y. et al. Very low carbohydrate diet significantly alters the serum metabolic profiles in obese subjects. J. Proteome Res. 12, 5801\u20135811 (2013).","journal-title":"J. Proteome Res."},{"key":"21744_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-020-03786-x","volume":"21","author":"D Liang","year":"2020","unstructured":"Liang, D. et al. IP4M: an integrated platform for mass spectrometry-based metabolomics data mining. BMC Bioinforma. 21, 444 (2020).","journal-title":"BMC Bioinforma."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-21744-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-21744-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-21744-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T05:59:14Z","timestamp":1669960754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-21744-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,5]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["21744"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-21744-w","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.739689890.793594627","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,5]]},"assertion":[{"value":"18 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1487"}}